Boussignac CPAP for Acute Cardiogenic Pulmonary Edema
Author Information
Author(s): Dieperink Willem, Jaarsma Tiny, van der Horst Iwan CC, Nieuwland Wybe, Vermeulen Karin M, Rosman Hanka, Aarts Leon PHJ, Zijlstra Felix, Nijsten Maarten WN
Primary Institution: University Medical Center Groningen, University of Groningen
Hypothesis
We hypothesized that the major obstacle in treating patients with BCPAP in the CCU would be organizational.
Conclusion
BCPAP was feasible, medically effective, and cost-effective in the treatment of acute cardiogenic pulmonary edema.
Supporting Evidence
- BCPAP treatment reduced hospital length of stay.
- Fewer patients required transfers to the intensive care unit for intubation.
- Estimated savings of approximately € 3,800 per patient were achieved with the BCPAP strategy.
Takeaway
Doctors used a special mask to help patients with breathing problems caused by heart issues, and it worked well and saved money.
Methodology
Patients with acute cardiogenic pulmonary edema were treated with BCPAP in a coronary care unit and compared to a historical control group receiving conventional treatment.
Limitations
The control group data is retrospective and the treatment might have differed slightly due to ongoing advances in treatment.
Participant Demographics
Patients were predominantly male with a mean age of 72 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website